PGHL — Procter & Gamble Health Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹103.65bn
- IN₹101.73bn
- IN₹9.34bn
- 82
- 13
- 96
- 74
Annual cashflow statement for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 9 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,333 | 2,534 | 3,142 | 2,733 | 3,116 |
| Depreciation | |||||
| Non-Cash Items | -4.8 | 2.3 | 134 | 249 | -44.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -156 | -1,112 | -1,197 | -973 | -1,551 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,473 | 1,695 | 2,360 | 2,283 | 1,687 |
| Capital Expenditures | -526 | -379 | -425 | -217 | -85.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 203 | 124 | 210 | 149 | 182 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -323 | -255 | -215 | -68.7 | 95.9 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3,866 | -2,886 | -985 | -4,181 | -2,347 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,716 | -1,446 | 1,160 | -1,967 | -565 |